Vitamina C y su acción en células cancerígenas

RESUMEN Introducción: La vitamina C es una sustancia que desde hace ya varios años ha suscitado debate debido a la cantidad de usos que se han demostrado. En algunos casos, las utilidades han ido desde profilaxis y acortamiento de la duración de resfriados, hasta estudios de acción en enfermedades, tales como el cáncer; los mecanismos de acción de esta han sido evaluados en forma de monoterapia o en combinación con quimioterapia para demostrar o descartar su utilidad en el cáncer. Objetivo: Demostrar si los efectos de la vitamina C fueron efectivos y si su uso, solo o en combinación con quimioterapia, es de utilidad. Método: Se realizó una investigación de tipo descriptiva documental, realizada con artículos científicos en el periodo comprendido desde 2016 hasta 2021, con un análisis detallado de los resultados del uso de la vitamina C y su posible efecto sobre los diferentes tipos de cáncer. Fueron buscados en las bases de datos de SciELO, Scopus y Medline. Resultados: La información hallada fue organizada según concentraciones plasmáticas de vitamina C y su acción en células cancerosas, dosis evaluadas de la vitamina C, mecanismos de acción en relación a células cancerígenas, desequilibrio redox, efecto específico en cánceres, vitamina C y cáncer de mama. Conclusiones: En la revisión realizada se evidencia que la vitamina C tiene un efecto benéfico en los cánceres hematopoyéticos, como: leucemia, melanoma, cáncer de mama o ciertos tipos de cáncer colorrectal y que disminuyen los efectos adversos producidos por medicamentos quimioterapéuticos.

ABSTRACT Introduction: Vitamin C is a water-soluble substance that has been in debate since a long time ago due to its wide demonstrated use. In some cases, its usage have ranged from prophylaxis and shortening the duration of colds, to studies of its action in diseases, such as cancer; Its mechanisms of action have been evaluated in the form of monotherapy or in combination with the chemotherapy to demonstrate or rule out its usefulness in cancer. Objective: To demonstrate whether the effects of vitamin C were effective and whether its use, alone or in combination with chemotherapy, is useful. Method: A documentary descriptive research was carried out, supported with scientific articles (period 2016 to 2021) which analyze in detail the results of the use of vitamin C and its possible effect on different types of cancer. Results: The information found was organized according to plasma concentrations of vitamin C, its action on cancer cells, evaluated doses of vitamin C, mechanisms of action in relation to cancer cells, redox imbalance, specific effect on cancers, vitamin C and breast cancer. Conclusions: The review shows that the use of vitamin C has a beneficial effect on hematopoietic cancers, such as leukemia, melanoma, breast cancer or certain types of colorectal cancer, and also reduces the adverse effects produced by chemotherapeutic drugs.

RESUMO Introdução: A vitamina C é uma substância que há vários anos desperta o debate devido ao número de usos que foram demonstrados. Em alguns casos, os benefícios vão desde a profilaxia e redução da duração dos resfriados, até estudos de ação em doenças, como o câncer; os mecanismos de ação deste foram avaliados como monoterapia ou em combinação com quimioterapia para provar ou descartar sua utilidade no câncer. Objetivo: Demonstrar se os efeitos da vitamina C foram eficazes e se seu uso, isoladamente ou em combinação com a quimioterapia, é útil. Método: Foi realizada uma pesquisa documental descritiva, realizada com artigos científicos no período de 2016 a 2021, com análise detalhada dos resultados do uso da vitamina C e seu possível efeito nos diferentes tipos de câncer. Eles foram pesquisados nas bases de dados SciELO, Scopus e Medline. Resultados: As informações encontradas foram organizadas de acordo com as concentrações plasmáticas de vitamina C e sua ação nas células cancerígenas, doses avaliadas de vitamina C, mecanismos de ação em relação às células cancerígenas, desequilíbrio redox, efeito específico sobre cânceres, vitamina C e câncer de mama. Conclusões: Na revisão realizada, fica evidente que a vitamina C tem efeito benéfico sobre os cânceres hematopoiéticos, como: leucemia, melanoma, câncer de mama ou certos tipos de câncer colorretal e que reduz os efeitos adversos produzidos pelos quimioterápicos.

Silencing LncRNA-DANCR attenuates inflammation and DSS-induced endothelial injury through miR-125b-5p / Silenciar LncRNA-DANCR atenúa la inflamación y la lesión endotelial inducida por DSS a través de miR-125b-5p

Background: LncRNA-DANCR is involved in inflammation and acts as a major contributor to colon cancer. The effects and mechanism of LncRNA-DANCR were first investigated in a DSS-induced colitis model in vivo and vitro. Material and methods: Sprague-Dawley rats were given DSS to induce the colitis model. TNF-α, IL-1β, IL-6 levels and expression of intestinal adhesion proteins ZO-1 and MUC2 in colon tissues and DSS-induced NCM460 cells were measured using corresponding kits. A hematoxylin and eosin (H&E) staining assay was performed to evaluate colon tissue pathology conditions. Protein expression levels in DSS-induced NCM460 cells were evaluated by Western blotting, and cell apoptosis was detected using a TUNEL assay. Gene levels in DSS-induced NCM460 cells were evaluated by PCR. The StarBase online tool was used to predict the LncRNA-DANCR target. The LncRNA-DANCR target was verified using a luciferase reporter assay. Results: LncRNA-DANCR was up-regulated in DSS-induced groups of rats. TNF-α, IL-1β and IL-6 expression was significantly increased in DSS-induced groups of rats and cells. Zo-1 and MUC2 expression levels were decreased in DSS-induced groups of rats. Silencing LncRNA-DANCR reduced inflammation, cell apoptosis and up-regulated ZO-1, MUC2 and Claudin-1 in DSS-induced cells. MiR-125b-5p was the downstream LncRNA-DANCR target. All LncRNA-DANCR effects in the colitis model were reversed by the miR-125b-5p inhibitor. Conclusion: LncRNA-DANCR/miR-125b-5p, which may act as a regulatory axis in inflammation, apoptosis and barrier function dysregulation, can provide an essential reference for the development of new drugs in colitis treatment.(AU)

Antecedentes: LncRNA-DANCR está involucrado en la inflamación y es uno de los mayores contribuyentes al cáncer de colon. Los efectos y el mecanismo de LncRNA-DANCR se investigaron por primera vez en el modelo de colitis inducido por DSS in vivo e in vitro. Material y métodos: Las ratas Sprague-Dawley recibieron DSS para inducir el modelo de colitis. Se midieron el nivel de TNF-α, IL-1, IL-6 y la expresión de proteínas de adhesión intestinal ZO-1 y MUC2 en los tejidos del colon y las células NCM460 inducidas por DSS utilizando los kits correspondientes. Se realizó un ensayo de tinción de hematoxilina y eosina (HE) para la evaluación de las condiciones patológicas del tejido del colon. El nivel de expresión de proteína en las células NCM460 inducidas por DSS se evaluó a través de Western blotting y se detectó apoptosis celular mediante el uso de un ensayo de TUNEL. El nivel genético en las células NCM460 inducidas por DSS se evaluó mediante un ensayo de PCR. La base estelar en línea se aplicó para predecir el objetivo de LncRNA-DANCR. El objetivo de LncRNA-DANCR fue verificado a través del ensayo Luciferase Reporter. Resultados: LncRNA-DANCR fue regulado en grupos inducidos por DSS en ratas. La expresión de TNF-α, IL-1 e IL-6 se incrementó significativamente en grupos inducidos por DSS en ratas y células. El nivel de expresión de Zo-1 y MUC2 disminuyó en los grupos inducidos por DSS en ratas. Silenciar LncRNA-DANCR redujo la inflamación, la apoptosis celular y el ZO-1, MUC2 y Claudin-1 regulados en células inducidas por DSS. MiR-125b-5p era el siguiente objetivo de lncRNA-DANCR. Todos los efectos de LncRNA-DANCR en el modelo de colitis fueron revertidos por el inhibidor miR-125b-5p. Conclusión: El LncRNA-DANCR/miR-125b-5p, que puede ser un eje regulador en la inflamación, la apoptosis y la desregulación de la función de barrera, puede proporcionar una referencia vital para el desarrollo de nuevos fármacos en el tratamiento de la colitis.(AU)

Silencing LncRNA-DANCR attenuates inflammation and DSS-induced endothelial injury through miR-125b-5p.

BACKGROUND: LncRNA-DANCR is involved in inflammation and acts as a major contributor to colon cancer. The effects and mechanism of LncRNA-DANCR were first investigated in a DSS-induced colitis model in vivo and vitro. MATERIAL AND METHODS: Sprague-Dawley rats were given DSS to induce the colitis model. TNF-α, IL-1ß, IL-6 levels and expression of intestinal adhesion proteins ZO-1 and MUC2 in colon tissues and DSS-induced NCM460 cells were measured using corresponding kits. A hematoxylin and eosin (H&E) staining assay was performed to evaluate colon tissue pathology conditions. Protein expression levels in DSS-induced NCM460 cells were evaluated by Western blotting, and cell apoptosis was detected using a TUNEL assay. Gene levels in DSS-induced NCM460 cells were evaluated by PCR. The StarBase online tool was used to predict the LncRNA-DANCR target. The LncRNA-DANCR target was verified using a luciferase reporter assay. RESULTS: LncRNA-DANCR was up-regulated in DSS-induced groups of rats. TNF-α, IL-1ß and IL-6 expression was significantly increased in DSS-induced groups of rats and cells. Zo-1 and MUC2 expression levels were decreased in DSS-induced groups of rats. Silencing LncRNA-DANCR reduced inflammation, cell apoptosis and up-regulated ZO-1, MUC2 and Claudin-1 in DSS-induced cells. MiR-125b-5p was the downstream LncRNA-DANCR target. All LncRNA-DANCR effects in the colitis model were reversed by the miR-125b-5p inhibitor. CONCLUSION: LncRNA-DANCR/miR-125b-5p, which may act as a regulatory axis in inflammation, apoptosis and barrier function dysregulation, can provide an essential reference for the development of new drugs in colitis treatment.

Effects of spermicidal extracts of Ananas comosus (pineapple) and Sapindus saponaria (jaboncillo) on cell viability, cytotoxicity and apoptosis / Efecto del extracto espermicida de Ananas comosus y Sapindus saponaria sobre la viabilidad, la citotoxicidad y la apoptosis celular

Introduction: there are natural products from different fruits and plants that are effective as spermicides, but it is important that they should have little or no cytotoxic effect on epithelial cells. Currently available spermicides with nonoxynol-9 cause vaginal irritation and damage to the vaginal mucosa, the uterine epithelium, and the microbial flora of the vagina. Objective: to elucidate the effect on cell viability, cytotoxicity and apoptosis of spermicidal extracts of Ananas comosus (L.) Merr. and Sapindus saponaria L. over HeLa cell line. Methods: both extracts were evaluated on HeLa cell line using the novel ApoTox-Glo™ Triplex Assay to determine whether cell viability, cytotoxicity and apoptosis were affected. Results: it was determined that treatment with Sapindus saponaria and Ananas comosus extracts initially affected cell viability, but the latter tended to be restored. There was a sign of cell apoptosis that also tended to decrease over time. Conclusions: extracts of Sapindus saponaria and Ananas comosus may affect the survival of cells at the beginning, but these can continue replicating over time. There was a sign of cell apoptosis that also tended to decrease over time. Something similar happened to cell cytotoxicity, indicating that although the extracts may affect the survival of cells at the beginning (6 hours of treatment), these can continue dividing over time.

Introducción: diversos compuestos de procedencia natural como frutos y plantas son altamente efectivos como espermicidas, pero es necesario que estos no tengan efecto citotóxico sobre las células epiteliales. Los espermicidas disponibles actualmente sobre la base de nonoxinol-9, causan irritación y daño en la mucosa, el epitelio uterino y la flora microbiana de la vagina. Objetivo: determinar el efecto sobre la viabilidad, citotoxicidad y apoptosis celular de extractos con actividad espermicida de Ananas comosus (L.) Merr. y Sapindus saponaria L. sobre la línea celular HeLa. Métodos: ambos extractos se evaluaron sobre la línea celular HeLa para determinar el efecto en la viabilidad, la citotoxicidad y la apoptosis celular, utilizando el novedoso ensayo triple ApoTox-Glo™. Resultados: inicialmente el tratamiento con los extractos de Sapindus saponaria y Ananas comosus afectaron la viabilidad celular; sin embargo, esta tendió a restablecerse y mantenerse en el tiempo. Asimismo, la señal de apoptosis celular tendió a disminuir a través de los tiempos de tratamiento. Conclusiones: los extractos de Sapindus saponaria y Ananas comosus podrían afectar la viabilidad celular inicialmente; sin embargo, estas continúan incrementándose con el paso del tiempo. Al mismo tiempo la señal de apoptosis celular disminuyó a través del tiempo y algo similar sucedió con la citotoxicidad celular, indicando que con el paso de las horas los extractos pueden afectar la proliferación celular al inicio (6 h de tratamiento), pero continúan proliferando.